GZA St Augustinus

Wilrijk 2610

0 studies enrolling now · 2 studies all time

What they study most

Ovarian Cancer, Solid Tumor

Studies at this site

• A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors — Completed
• A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer — Completed